Testing effectiveness (Phase 2)Study completedNCT00859937
What this trial is testing
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
Who this might be right for
Malignant Salivary Gland NeoplasmRecurrent Salivary Gland CarcinomaSalivary Gland Adenoid Cystic Carcinoma+1 more
National Cancer Institute (NCI) 55